CVT-12012

Modify Date: 2024-01-12 12:02:48

CVT-12012 Structure
CVT-12012 structure
Common Name CVT-12012
CAS Number 1018675-35-8 Molecular Weight 434.41200
Density N/A Boiling Point N/A
Molecular Formula C21H21F3N4O3 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CVT-12012


CVT-12012 is a potent and orally bioavailable stearoyl-coA desaturase (SCD) inhibitor, with IC50s of 38 nM, 6.1 nM for rat microsomal and human HEPG2, respectively.

 Names

Name 2-hydroxy-N-[2-[3-methyl-2-oxo-7-[[3-(trifluoromethyl)phenyl]methylamino]quinoxalin-1-yl]ethyl]acetamide
Synonym More Synonyms

 CVT-12012 Biological Activity

Description CVT-12012 is a potent and orally bioavailable stearoyl-coA desaturase (SCD) inhibitor, with IC50s of 38 nM, 6.1 nM for rat microsomal and human HEPG2, respectively.
Related Catalog
Target

IC50: 38 nM (rat microsomal), 6.1 nM (human HEPG2)[1][2].

In Vitro CVT-12012 (Compound 5b) displays the highest potency in both the microsomal and the HEPG2 SCD assays (IC50 38 nM and 6.1 nM, respectively) compared to the other methyl-substituted compounds[1].
In Vivo In a rat PK study, CVT-12012 demonstrates good oral bioavailability (78%). It appears that the oral absorption of CVT-12012 is not affected by a significant Pgp efflux, which is expected based on Caco-2 assay result. The plasma clearance of CVT-12012 is high (88 mL/min/kg) with elimination half-life of approximately 1 h[1].
References

[1]. Koltun DO, et al. Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4070-4.

[2]. Atkinson KA, et al. N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. Bioorg Med Chem Lett. 2011 Mar 15;21(6):1621-5.

 Chemical & Physical Properties

Molecular Formula C21H21F3N4O3
Molecular Weight 434.41200
Exact Mass 434.15700
PSA 99.74000
LogP 3.35760
Storage condition 2-8℃

 Precursor & DownStream

Precursor  1

DownStream  0

 Synonyms

unii-oh3j29q653